Elevated systolic blood pressure showed a dose-response relationship with severe COVID-19 for those taking antihypertensive meds.
Significant reductions were seen in blood pressure and LDL-C at six and 12 months for patients enrolled in the remote program.
Dose-dependent reductions in systolic blood pressure were seen in the phase 2 dose-ranging study.
Systolic and diastolic blood pressure increased by 1.79 and 1.30 mm Hg, respectively, during the pandemic versus the prepandemic period.
Lowering blood pressure with antihypertensive treatment may reduce the risk for incident dementia in older adults with a history of hypertension.
A beneficial effect was seen over a median intervention period of 3.3 years but did not persist at median follow-up of 8.8 years.
Age at hypertension and type 2 diabetes diagnoses were linked to age at the onset of primary open-angle glaucoma. No link was found for obstructive sleep apnea or migraine.
Among adults with three or more chronic conditions, Medicare was the most frequently observed expected source of payment.
The small effects of LSSS versus regular salt on cardiovascular health in adults may be important when implemented at the population level
Self-measured blood pressure paired with a connected smartphone app is not superior to standard self-measured blood pressure for blood pressure reduction and patient satisfaction.
Please login or register first to view this content.